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Introduction
Asthma and attention-deficit/hyperactivity disorder (ADHD) are both common chronic disorders affecting children. Asthma is characterized by wheezing, breathlessness and chest tightness affecting about 6-8% in childhood and adolescence (1) . ADHD is characterized, according to DSM-IV by hyperactivity-impulsivity (HI) and inattention (IN) with a prevalence of 3-5% in school-aged children (2) . Several previous studies, including a metaanalysis (3), have shown an association between asthma and ADHD symptoms (4) (5) (6) , though studies do exist where a relationship was not found (7, 8) . One study of 102,253 children from the National Survey of Children's Health showed a two-fold increased prevalence of ADHD among children with asthma, and even higher rates of ADHD among children with severe asthma (9) . Similar dose-response effects have been observed in relation to broad assessments of behavioral problems (10, 11) .
The nature of the relationship between asthma and ADHD is not entirely clear. None of the previous studies have distinguished between the two DSM-IV ADHD symptom dimensions, which is a critical issue as HI and IN have partly distinct etiologies (12) and developmental outcomes (13) . All of the prior asthma-ADHD association studies have been cross-sectional, which constrains possibilities to study the direction of effect and the developmental link between the two conditions. In addition, possible mechanisms underlying this association remain to be investigated.
Firstly, the association between asthma and ADHD could be due to shared risk factors. Low birth weight, impaired fetal growth and low socioeconomic status are known risk factors for asthma (14, 15) and ADHD (16, 17) . None of the previous studies on the asthma-ADHD association have adjusted for birth weight, while most studies have adjusted for gender and different measures of socioeconomic status (5, 9, 10) with remaining stable estimates.
Secondly, the link asthma-ADHD may be due to asthma medication such as inhaled corticosteroids (ICS). There have been case reports of altered behavior and psychosis in small children using ICS (18) , but larger studies suggest no evidence of major adverse neuropsychiatric effects (19) . One study was able to show higher rates of hyperactivity in children with asthma compared to healthy controls; however the rates were similar to other children under specialist care for non-respiratory complaints, indicating that ICS does not affect behavior (20) .
Thirdly, shared genetic factors could account for the observed association between asthma and ADHD. However, although twin studies consistently have shown that asthma and ADHD are heritable disorders (12, 21) examinations of genetic and shared contributions to the overlap between the two conditions is still lacking. Two previous family-based studies have examined the potential impact of familial effects for the association, but failed to find support for such a conclusion (8, 22) . Clearly, additional research is needed to clarify this issue.
Our overall aim was to study the longitudinal relationship between childhood asthma and ADHD in adolescence, including genetic and other confounding factors and the impact of asthma medication in a prospective study of 1,480 twin pairs followed from 8-9 to 13-14 years of age. We used a quantitative measure of ADHD to assess DSM-IV symptoms of hyperactivity-impulsivity and inattention, since sophisticated statistical modeling techniques have been used to show that ADHD exists on a severity continuum (23) .
Methods

Study design and population
The Twin study of CHild and Adolescent Development (TCHAD) is a longitudinal study from childhood onwards. Study population and data collection has been described elsewhere (24) . Data was collected by parental questionnaires when twins born between May 1985 and December 1986 were 8-9 (wave 1, response rate 74.9 %) and 13-14 (wave 2) years old, Figure 1 . The waves were separate, so that non-responders from wave 1 were still eligible for participation at age 13-14.
Variables
Asthma was measured as a main outcome by using the standardized question in the International study of Asthma and Allergies in Childhood (ISAAC) study "Has your child ever had asthma" (yes/no). If "yes", follow-up questions regarding age of onset and number of asthma episodes in the previous year were asked. Eczema was measured by the standardized question "Has your child ever had eczema" (yes/no).
Parents provided ratings of ADHD symptoms in their children via a checklist of 14 DSM-IV based items (2) and were asked to check symptoms persisting for at least six months (0/1). A hyperactivity-impulsivity scale was created from the sum of 8 symptoms of hyperactivityimpulsivity listed in DSM-IV and an inattention scale from the sum of 6 items related to Birth weight data was obtained by linking data from TCHAD to the Swedish Medical Birth Register as previously described (16) and categorized into 500 gram intervals.
Socioeconomic status was classified according to the Nordic standard occupational classification and Swedish socio-economic classification (SEI) (26).
Medication was assessed in the questionnaire with the question "does this child use medication on a regular basis". All individuals with reported ICS and/or inhaled β2-agonist were considered using asthma medication. The questions on zygosity have been validated with DNA markers in previous studies and proved correct in 95% (24) .
Statistical analysis
Odds ratio (OR) with 95% confidence intervals (CI) for the associations between asthma, HI and IN were estimated using the logit link in generalized estimating equations (GEE), which allow us to account for the dependent nature of the twin observations. The longitudinal analyses were exploratory and involved a series of regression models with the multiple dichotomized variables of HI or IN at age 13-14 as outcome variables and asthma at age 8-9
as a predictor. The models were applied with and without controlling for well established covariates, including sex, socioeconomic status, birth weight and eczema. We also added ADHD symptoms at age 8-9 into the model, to estimate the effect of asthma at age 8/9 on increasing HI/IN symptoms between age 8/9 and 13/14. Only data from children with complete answers on asthma, HI and IN were used in the fully adjusted model.
All the statistical analyses were performed in the SAS 9.1.3 using GENMOD procedure (SAS Institute, Inc., Cary, NC.).
Twin methods were used to examine how genetic and environmental factors contribute to the association between asthma and ADHD. 
Results
The total study population consisted of all 1,812 responders with data on asthma and ADHD symptoms either at age 8-9, age 13-14 or both (Figure 1 ). In total, 2,134 children had complete answers on asthma and symptoms of ADHD (HI and IN) at age 8-9, 1,883 children had complete answers at age 13-14 and 1,754 children had complete answers at both ages. Table 1 shows rates of asthma HI-3 and IN-3 by background characteristics. Boys showed higher rates of asthma and IN-3. Socioeconomic status was significantly associated with HI and IN at age 8-9 and age 13-14, and birth weight was significantly associated with HI at age 8-9. Almost identical results were observed for all other levels of HI and IN (e.g. HI-4, HI-5, HI-6), data not shown.
In the cross-sectional analyses on the association between asthma and ADHD (HI and IN), the prevalence of twins with asthma increased in the higher categories of HI and IN at both age 8-9 and 13-14. The increase was continuous throughout the categories, although not significant at all levels ( Table 2 ).
In the longitudinal analyses, children with asthma at age 8-9 were more likely to have parentreported symptoms of HI at age 13-14 (Table 3 ) and more than two-fold increased risk of HI-3 at age 13-14 (OR 2.50, 95% CI 1.46-4.28) in the unadjusted models. The results were stable after adjusting for sex, birth weight and socioeconomic status. Results also remained at same level after adjustment for previous HI and IN symptoms (OR 2.73, 95% CI 1.49-5.00), suggesting an effect of asthma on change in ADHD symptoms. In stratified analyses of children without early symptoms of ADHD, OR remained stable. The association between asthma and HI did not change with adjustment for eczema (Table 3) .
Asthma at age 8-9 was also associated with a significantly increased risk of IN 4-6 (ranging from OR 2.77, 95% CI 1.23-6.26 to OR 8.36, 95% CI 1.52-45.81). However, none of these associations were significant in the adjusted model. Fifty-eight (44.6%) of the 130 asthmatic children with information regarding asthma medication at age 8-9 were using asthma medication on a regular basis at age 8-9, and fifty (35.5%) out of 141 at age 13-14. There was no significant difference in HI between asthmatic children with or without asthma medication.
Twin analyses were limited to HI-3, because higher cut-off values (i.e., HI-4, HI-5, HI-6) resulted in cells with few of zero participants. Table 4 shows intra-class and cross-trait crosstwin (CTCT; the correlation between twin1's status on asthma and the co-twin's status on HI)
correlations for asthma at age 8-9 and HI-3 at age 13-14, by zygosity. MZ intra-class and CTCT correlations were consistently higher than the corresponding DZ correlations, suggesting substantial genetic influences on HI-3, asthma as well as on the overlap between the phenotypes. Bivariate liability threshold modelling suggest that the variance in liability of asthma was explained by genetic (74%; 95% CI: 0.69-0.86) and non-shared environmental influences (26%; 0.14-0.33) influences. The variance in liability of HI-3 was explained by genetic (76%; 0.58-0.88) and non-shared environmental (24%; 0.12-0.42) influences. The genetic and non-shared environmental correlations between asthma and HI-3 were estimated as 0.21 (0.00-0.51) and 0.29 (0.00-0.64), respectively. Calculations of the genetic and nonshared environmental contribution to the phenotypic correlation revealed that 68% of the phenotypic correlation between asthma and HI-3 (r = 0.23, 0.04-0.37) was due to genetic influences.
Discussion
We found that children with asthma at age 8-9 had an almost twofold increased risk of parentreported HI at age 13-14, compared with children without asthma. The association was consistent also after adjustment for potential confounders. Results from the twin analyses indicate that the association between asthma and HI could be in part due to genetic influences.
Thus our results, based on the first twin study on the longitudinal association between asthma and ADHD, support the hypothesis that there is a genetic overlap between asthma and HI phenotypes.
Previous studies have shown a cross-sectional association between asthma and ADHD or HI (5, 6, 9, 20) . Important strengths of the current study are that the relationship between asthma and ADHD symptoms was examined prospectively over time, and that the two ADHD dimensions were assessed separately (13). Our study shows that childhood asthma predicts HI in adolescence but not IN, which provide further support for the distinction between the two symptom dimensions of ADHD. In line with the dimensional model of ADHD (23, 28, 29) , the prospective asthma-HI link was observed across the range of severity in HI symptoms, and an almost linear increase in risk was seen for each additional HI symptom, which highlight the need for studies that evaluate how asthma is involved in the transition from milder to more severe levels of ADHD symptoms.
The association between parent-reported asthma and HI was stable for sex, birth weight and socioeconomic status. We saw an effect of low birth weight and socioeconomic status on ADHD symptoms at age 8-9 which was expected (16, 17) , however birth weight and socioeconomic status had no effect of on asthma, in contrast to previous studies (14, 15) .
Recent studies have shown a relationship between ADHD, atopic eczema and sleeping problems (30, 31) . We did not find any differences in the association between asthma and symptoms of hyperactivity-impulsivity when adjusting for eczema. Our confounding measures of socioeconomic status, birth weight and eczema may not be strong enough to detect confounding, which could result in an overestimation of the association between asthma and ADHD symptoms. Moreover, our study did not show any significant differences regarding asthma medication and level of HI, which highlights the need of future studies (20) .
The results from the twin analysis extends previous research by showing that the association between asthma and HI symptoms is partly influenced by genetic effects. However, despite the large sample, extreme levels of HI/IN and new cases of asthma were rare at age 13-14, which constrains the power of the twin analysis. It should also be noted that our results are inconsistent with two previous family-based studies (8, 22 ) that failed to identify a familial component underlying the asthma-ADHD association. Both previous studies were based upon a clinically referred sample, used DSM-III-criteria and did not distinguish between HI and IN.
Nevertheless, our finding of a genetic overlap between asthma and HI should be considered in future molecular genetic investigations.
This study should be interpreted in the context of its limitations. First, asthma and symptoms of ADHD were assessed using parent-report questionnaires and it is important to underline that this is not equivalent to a diagnosis of ADHD. Also, relying on a single source of informant (i.e, parent-report) to assess ADHD symptoms could be considered to be a limitation of our study. Second, twin studies may not be generalizable, although studies indicate that twins do not differ from singletons concerning risk of asthma (32) while the results regarding ADHD are mixed (33, 34) .
Third, although the response rate of this study was relatively high selective attrition is always a concern in longitudinal studies, however previous studies (25, 35) have suggested that bias due to selective attrition is limited.
Fourth, we did not have information on age of onset of ADHD and the possibilities to draw causal conclusions are constrained. For example, we cannot rule out that the observed association between asthma and HI may in part be explained by the presence of unmeasured ADHD symptoms in early childhood. In conclusion, this population-based longitudinal study indicates that early asthma is associated with an increased risk of elevated levels of hyperactivity-impulsivity later in life. These findings highlight the need for increased clinical attention to problems associated with ADHD symptoms in asthmatic children. Exploring the association between asthma and ADHD further may provide better opportunities to target early intervention and support to these children and their families. Note. N, number of twin pairs; MZ, monozygotic; DZ dizygotic.
